PMID: 11907503Mar 22, 2002Paper

High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval

Journal of the American Academy of Dermatology
Uwe WollinaHelga Konrad

Abstract

Axillary hyperhidrosis is a common condition that can be personally distressing and can interfere with professional and social life. Intracutaneous injections of botulinum toxin type A (BTXA) have recently been shown to induce an effective but temporary anhidrosis, usually for 4 to 6 months. High-dose BTXA was shown to have a lower relapse rate, but it remained unclear whether it could induce a prolongation of the antihidrotic effect. Our aim was to evaluate the long-term effectiveness of "high-dose" botulinum toxin therapy in axillary hyperhidrosis, the response to repeated treatment, and the possible side effects. In an open study in a university medical center, 47 patients with axillary hyperhidrosis unresponsive to previous therapies were treated with intracutaneous injections of botulinum A toxin. A total dose of 200 U of BTXA was used per axilla. Patients were followed up for periods up to 29 months. The main outcome measures were patients' satisfaction with the antihidrotic effect, response to repeated treatment, and safety of treatment. Within 6 days of the injection of BTXA, all patients reported cessation of excessive sweating. The follow-up was 17.0 +/- 8.3 months (range, 3-29 months). The relapse rate within 12 mont...Continue Reading

References

Jun 1, 1991·Journal of the American Academy of Dermatology·K SatoG Samman
Jul 1, 1996·Clinical and Experimental Dermatology·K O BusharaH S Schutta
Apr 1, 1998·Archives of Dermatology·M NaumannK Reiners
Apr 2, 1998·Archives of Physical Medicine and Rehabilitation·I R Odderson
Apr 29, 1998·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M HeckmannG Plewig
Oct 23, 1998·Nature Structural Biology·D B LacyR C Stevens
Nov 5, 1998·Archives of Dermatology·M HeckmannG Plewig
Jan 19, 1999·Dermatologic Clinics·L P Stolman
Feb 17, 1999·The British Journal of Dermatology·M NaumannK Reiners
May 16, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H NaverS M Aquilonius
Jul 25, 2000·Journal of the American Academy of Dermatology·W HuangA S Rogachefsky
Aug 24, 2000·Aesthetic Plastic Surgery·A Goldman
Feb 15, 2001·The New England Journal of Medicine·M HeckmannUNKNOWN Hyperhidrosis Study Group

❮ Previous
Next ❯

Citations

Jan 24, 2007·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Thomas SychaEduard Auff
Aug 21, 2003·American Journal of Clinical Dermatology·Samireh SaidJean Carruthers
Apr 17, 2008·The Australasian Journal of Dermatology·Sanaz DavarianAbbas Rahimi
Aug 6, 2020·Scientific Reports·Choongjin BanDae-Hyuk Kweon
Jul 31, 2007·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Nowell SolishUNKNOWN Canadian Hyperhidrosis Advisory Committee
Jan 20, 2012·The Korean Journal of Pain·Hyun Ho LeeChan Kim
Feb 19, 2009·American Journal of Clinical Dermatology·Alexander GrunfeldNowell Solish
Jul 17, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·E ForbatF Al-Niaimi
Oct 13, 2017·Muscle & Nerve·Ib R Odderson
Dec 23, 2017·Health Technology Assessment : HTA·Ros WadeNerys Woolacott
Jun 29, 2010·Seminars in Cutaneous Medicine and Surgery·Jane Sanders Bellet
Jul 1, 2011·American Journal of Clinical Dermatology·Hobart W Walling, Brian L Swick
Jul 17, 2008·The Journal of Dermatological Treatment·Wendy Jane KoeyersGertruud Krekels
Oct 30, 2013·International Journal of Dermatology·Juliano de Avelar BreunigHiram de Almeida
Jul 16, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Franziska BrehmerKai-Martin Thoms
Dec 17, 2004·Clinical Neuropharmacology·Joseph JankovicMarkus Naumann
Dec 21, 2004·The British Journal of Dermatology·N LoweH Hamm
Jul 28, 2006·Parkinsonism & Related Disorders·Daniel D Truong, Wolfgang H Jost

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.